Selective Autoantibody Production against CCL3 Is Associated with Human Type 1 Diabetes Mellitus and Serves As a Novel Biomarker for Its Diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective Autoantibody Production against CCL3 Is Associated with Human Type 1 Diabetes Mellitus and Serves As a Novel Biomarker for Its Diagnosis

Published:2009-06-03 Issue:12 Volume:182 Page:8104-8109
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Shehadeh Naim,Pollack Shirly,Wildbaum Gizi,Zohar Yaniv,Shafat Itay,Makhoul Reem,Daod Essam,Hakim Fahed,Perlman Rina,Karin Nathan

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Beneficial Autoimmunity to Proinflammatory Mediators Restrains the Consequences of Self-Destructive Immunity

2. ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

3. A Targeted DNA Vaccine Augments the Natural Immune Response to Self TNF-α and Suppresses Ongoing Adjuvant Arthritis

4. Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and Rat

5. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain;Molecules;2023-07-30

2. The chemokine landscape: one system multiple shades;Frontiers in Immunology;2023-05-11

3. Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model;Brain Sciences;2023-03-29

4. Classical and new candidate biomarkers for developing biosensors in diagnosing diabetes and prediabetes; past, present and future;Advanced Sensor Technology;2023

5. Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis;Diabetes and Vascular Disease Research;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3